These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16985075)

  • 1. Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.
    Tyler MA; Ulasov IV; Borovjagin A; Sonabend AM; Khramtsov A; Han Y; Dent P; Fisher PB; Curiel DT; Lesniak MS
    Mol Cancer Ther; 2006 Sep; 5(9):2408-16. PubMed ID: 16985075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD46 represents a target for adenoviral gene therapy of malignant glioma.
    Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
    Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
    Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
    Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.
    Ulasov IV; Rivera AA; Han Y; Curiel DT; Zhu ZB; Lesniak MS
    J Neurosurg; 2007 Sep; 107(3):617-27. PubMed ID: 17886563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.
    Toh ML; Hong SS; van de Loo F; Franqueville L; Lindholm L; van den Berg W; Boulanger P; Miossec P
    J Immunol; 2005 Dec; 175(11):7687-98. PubMed ID: 16301679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.
    Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS
    Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
    Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
    Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
    Nakamura T; Sato K; Hamada H
    Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.
    Ulasov IV; Tyler MA; Han Y; Glasgow JN; Lesniak MS
    Hum Gene Ther; 2007 Feb; 18(2):118-29. PubMed ID: 17328684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
    Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
    Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma.
    Hoffmann D; Heim A; Nettelbeck DM; Steinstraesser L; Wildner O
    Hum Gene Ther; 2007 Jan; 18(1):51-62. PubMed ID: 17184155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
    Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
    Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.
    Yotnda P; Zompeta C; Heslop HE; Andreeff M; Brenner MK; Marini F
    Hum Gene Ther; 2004 Dec; 15(12):1229-42. PubMed ID: 15684699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fiber-modified adenovirus co-expressing HSV-TK and Coli.NTR enhances antitumor activities in breast cancer cells.
    Zhan Y; Yu B; Wang Z; Zhang Y; Zhang HH; Wu H; Feng X; Geng RS; Kong W; Yu XH
    Int J Clin Exp Pathol; 2014; 7(6):2850-60. PubMed ID: 25031704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism.
    Volk AL; Rivera AA; Kanerva A; Bauerschmitz G; Dmitriev I; Nettelbeck DM; Curiel DT
    Cancer Biol Ther; 2003; 2(5):511-5. PubMed ID: 14614316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D; Meyer B; Wildner O
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients.
    Brouwer E; Havenga MJ; Ophorst O; de Leeuw B; Gijsbers L; Gillissen G; Hoeben RC; ter Horst M; Nanda D; Dirven C; Avezaat CJ; Goudsmit J; Sillevis Smitt P
    Cancer Gene Ther; 2007 Feb; 14(2):211-9. PubMed ID: 17082793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.